[{"id":"e18ff721-21d9-4248-a104-f2107550bd00","acronym":"","url":"https://clinicaltrials.gov/study/NCT02662634","created_at":"2021-01-18T12:58:30.326Z","updated_at":"2024-07-02T16:36:15.171Z","phase":"Phase 2","brief_title":"A Safety and Feasibility Study of AGS-003-LNG for the Treatment of Stage 3 Non Small Cell Lung Cancer","source_id_and_acronym":"NCT02662634","lead_sponsor":"GU Research Network, LLC","biomarkers":" CD8","pipe":"","alterations":" ","tags":["CD8"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cisplatin • carboplatin • albumin-bound paclitaxel • pemetrexed • rocapuldencel-T (CMN-001)"],"overall_status":"Withdrawn","enrollment":"","initiation":"Initiation: 03/01/2016","start_date":" 03/01/2016","primary_txt":" Primary completion: 03/01/2018","primary_completion_date":" 03/01/2018","study_txt":" Completion: 03/01/2018","study_completion_date":" 03/01/2018","last_update_posted":"2022-03-18"},{"id":"065bb339-f105-4508-b885-dd7c099feef1","acronym":"","url":"https://clinicaltrials.gov/study/NCT02944357","created_at":"2021-01-18T14:27:27.728Z","updated_at":"2024-07-02T16:37:16.298Z","phase":"","brief_title":"Gemcitabine Hydrochloride, Cisplatin, and AGS-003-BLD in Treating Patients With Muscle-Invasive Bladder Cancer Undergoing Surgery","source_id_and_acronym":"NCT02944357","lead_sponsor":"Mayo Clinic","biomarkers":" CD8 • PD-1","pipe":" | ","alterations":" PD-1 elevation","tags":["CD8 • PD-1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e PD-1 elevation"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cisplatin • gemcitabine • rocapuldencel-T (CMN-001)"],"overall_status":"Withdrawn","enrollment":"","initiation":"Initiation: 11/01/2016","start_date":" 11/01/2016","primary_txt":" Primary completion: 09/05/2017","primary_completion_date":" 09/05/2017","study_txt":" Completion: 09/05/2017","study_completion_date":" 09/05/2017","last_update_posted":"2017-11-17"}]